Filing Details
- Accession Number:
- 0001618835-19-000184
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-21 20:18:28
- Reporting Period:
- 2019-11-20
- Accepted Time:
- 2019-11-21 20:18:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1618835 | Evofem Biosciences Inc. | EVFM | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1251371 | L Saundra Pelletier | C/O Evofem Biosciences, Inc. 12400 High Bluff Drive, Suite 600 San Diego CA 92130 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-11-20 | 22,657 | $5.74 | 424,676 | No | 4 | F | Direct | |
Common Stock | Disposition | 2019-11-21 | 10,000 | $6.01 | 414,676 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on November 20, 2019. No shares were sold in connection with this transaction.
- These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2019.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.